We are live on ! Find out more
MP

Mangrove Partners Portfolio holdings

AUM $1.24B
1-Year Est. Return 41.74%
This Fund
S&P 500
This Quarter Est. Return
+24.95%
1 Year Est. Return
+41.74%
3 Year Est. Return
+169.22%
5 Year Est. Return
+150.23%
10 Year Est. Return
+417.9%
AUM
$1.44B
AUM Growth
-$42.2M
Cap. Flow
-$133M
Cap. Flow %
-9.26%
Top 10 Hldgs %
29.23%
Holding
202
New
26
Increased
19
Reduced
11
Closed
39

Top Buys

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$34.8M
2
X
US Steel
X
+$34.6M
3
AGR
Avangrid, Inc.
AGR
+$32.7M
4
WS icon
Worthington Steel
WS
+$26.7M
5
CTLT
CATALENT, INC.
CTLT
+$25M

Top Sells

Rank Stock Value
1
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$64.7M
2
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$62.7M
3
WFRD icon
Weatherford International
WFRD
+$56.8M
4
DELL icon
Dell
DELL
+$37.5M
5
SPLK
Splunk Inc
SPLK
+$32M

Sector Composition

Rank Sector Weight
1 Healthcare 12.86%
2 Consumer Discretionary 12.47%
3 Financials 11.09%
4 Industrials 7.54%
5 Communication Services 6.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CPRI icon
26
Capri Holdings
CPRI
$1.82B
$18.4M 1.28%
405,344
+177,229
+78% +$8.44M
SGI
27
Somnigroup International
SGI
$15.3B
$18.1M 1.26%
318,768
-320,000
-50% -$16.7M
PPLI
28
People Inc
PPLI
$3.15B
$18.1M 1.26%
412,806
– –
CIG icon
29
CEMIG Preferred Shares
CIG
$6.18B
$17.6M 1.22%
9,255,901
-1,082,900
-10% -$1.94M
NGMS
30
DELISTED
NeoGames S.A. Ordinary Shares
NGMS
$16.6M 1.16%
574,869
– –
ANAB icon
31
AnaptysBio
ANAB
$1.59B
$15.5M 1.08%
+689,521
New +$16.3M
HA
32
DELISTED
Hawaiian Holdings, Inc.
HA
$14.9M 1.03%
+1,115,125
New +$15.5M
MCACW
33
DELISTED
Monterey Capital Acquisition Corporation Warrants
MCACW
$14.2M 0.99%
1,280,455
– –
PTGX icon
34
Protagonist Therapeutics
PTGX
$8.72B
$12.7M 0.88%
439,314
– –
OLK
35
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
$12.7M 0.88%
+540,366
New +$13M
SBCWW
36
SBC Medical Group Warrants
SBCWW
$2.99M
$11.8M 0.82%
930,091
– –
LNTH icon
37
Lantheus
LNTH
$7.03B
$10.8M 0.75%
173,868
– –
ZTR
38
Virtus Total Return Fund
ZTR
$340M
$10.8M 0.75%
1,942,500
+70,112
+4% +$375K
MSSAW
39
DELISTED
Metal Sky Star Acquisition Corporation Warrant
MSSAW
$10.5M 0.73%
951,094
– –
GLLIW
40
DELISTED
Globalink Investment Inc. Warrants
GLLIW
$10.4M 0.72%
950,000
– –
RFACW
41
DELISTED
RF Acquisition Corp. Warrants
RFACW
$10.3M 0.71%
950,100
– –
AOGOW
42
DELISTED
Arogo Capital Acquisition Corp. Warrant
AOGOW
$10.2M 0.71%
949,909
– –
IMAQW
43
DELISTED
International Media Acquisition Corp. Warrants
IMAQW
$10.2M 0.71%
900,000
– –
CNGLW
44
DELISTED
Canna-Global Acquisition Corp Warrant
CNGLW
$10M 0.7%
906,104
– –
AFARW
45
DELISTED
Aura FAT Projects Acquisition Corp Warrant
AFARW
$9.96M 0.69%
900,000
– –
FFC
46
Flaherty & Crumrine Preferred and Income Securities Fund
FFC
$775M
$9.81M 0.68%
660,629
+11,771
+2% +$169K
YOTAW
47
DELISTED
Yotta Acquisition Corporation Warrant
YOTAW
$9.79M 0.68%
904,000
– –
GLSTW
48
DELISTED
Global Star Acquisition, Inc. Warrants
GLSTW
$9.6M 0.67%
896,704
– –
FLFVW
49
DELISTED
Feutune Light Acquisition Corporation Warrant
FLFVW
$9.25M 0.64%
850,749
– –
URG
50
Ur-Energy
URG
$489M
$8.93M 0.62%
5,580,851
– –
1
2
3 4 5

Similar funds

GX
Greylock XIV Menlo Park, California $1.24B AUM
HCA
Harbor Capital Advisors Chicago, Illinois $1.23B AUM 30.56% 1-Year Est. Return
CA
Cullinan Associates Louisville, Kentucky $1.24B AUM 28.12% 1-Year Est. Return
WTA
Washington Trust Advisors Wellesley, Massachusetts $1.24B AUM 22.58% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
FLII
First Long Island Investors Jericho, New York $1.23B AUM 14.42% 1-Year Est. Return
CCA
Clearwater Capital Advisors Hoffman Estates, Illinois $1.24B AUM 15.23% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Mangrove Partners's Q1 2024 Portfolio in Review

As of Q1 2024, Mangrove Partners held 202 positions worth $1.44B, down 2.8% from $1.48B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Mangrove Partners withdrew a net $133M in Q1 2024, closing 39 positions and reducing 11 holdings. Its most notable exit was Mirati Therapeutics, Inc. Common Stock, an estimated $64.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 8.6% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, Mangrove Partners opened a new position in Teva Pharmaceuticals worth $39M.

  • Mangrove Partners's largest Q1 2024 buy was Teva Pharmaceuticals: 2,762,154 shares worth $39M.
  • Mangrove Partners added most to US Steel in Q1 2024, an estimated $34.6M increase.
  • Mangrove Partners's biggest Q1 2024 reduction was iShares Core S&P Small-Cap ETF, cutting an estimated $62.7M.
  • Mangrove Partners fully exited Mirati Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $64.7M.
  • Mangrove Partners's ten largest holdings make up 29% of its $1.44B portfolio in Q1 2024.
  • Mangrove Partners opened 26 new positions and closed 39 in Q1 2024.
  • Mangrove Partners's portfolio value fell 2.8% quarter-over-quarter to $1.44B.

Based on Mangrove Partners's 13F filing for Q1 2024, filed 15 May 2024.